Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 1;157(10):1236-1237.
doi: 10.1001/jamadermatol.2021.3341.

Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis

John S Barbieri  1 , Joel M Gelfand  1   2
Affiliations

Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis

John S Barbieri et al. JAMA Dermatol. .

Abstract

This cross-sectional study assesses patient-reported outcome measures as a complement to clinician-reported outcome measures in psoriasis treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Gelfand reported receiving consulting fees from Bristol Myers Squibb, Boehringer Ingelheim, GlaxoSmithKline, Janssen, Novartis, Regeneron Pharmaceuticals, UCB (Data Safety and Monitoring Board), Sanofi, and Pfizer and receiving research grants (to the trustees of the University of Pennsylvania) from AbbVie, Amgen, Celgene, Janssen, Novartis, Ortho Dermatologics, Pfizer, and Sanofi. No other disclosures were reported.

References

    1. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433-1440. doi:10.1001/archderm.1997.03890470111018 - DOI - PubMed
    1. Penn Medicine Dermatology. Dermatology Clinical Effectiveness Research Network (DCERN). 2021. Accessed July 29, 2021. https://dermatology.upenn.edu/dcern/
    1. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol. 2005;125(4):659-664. doi:10.1111/j.0022-202X.2005.23621.x - DOI - PubMed
    1. Smith CH, Jabbar-Lopez ZK, Yiu ZZ, et al. . British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017. Br J Dermatol. 2017;177(3):628-636. doi:10.1111/bjd.15665 - DOI - PubMed
    1. Amatore F, Villani A-P, Tauber M, Viguier M, Guillot B; Psoriasis Research Group of the French Society of Dermatology (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie) . French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults. J Eur Acad Dermatol Venereol. 2019;33(3):464-483. doi:10.1111/jdv.15340 - DOI - PMC - PubMed